The standard criteria include: BMI of 30 kg/m or greater , or BMI of 27 kg/m or greater with at least one weight-related comorbidity (type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea, or cardiovascular disease) Documentation of a structured dietary and exercise program lasting at least 3 to 6 months that did not produce clinically meaningful weight loss (typically defined as 5% or more of body weight) The prescriber is a physician, nurse practitioner, or physician assistant (telehealth prescribers are generally accepted if licensed in North Carolina) Step Therapy Rules Some BCBSNC plans enforce step therapy before Wegovy approval
J.RehalS.ShinJ
Clinical data show that ACSL1 exhibits a positive correlation with FSP1, while it shows a negative correlation with 4-hydroxynonenal (4-HNE) and prostaglandin-endoperoxide synthase 2 (PTGS2)
Alterations in the normal function of excitatory amino acid carrier 1 affect cysteine transport and GSH synthesis impairing zinc homeostasis (the thiol group of GSH can function as a principal Zn 2+ chelator for the maintenance of Zn 2+ homeostasis in neurons) and oxidative stress, enhancing susceptibility to ischemia-induced neuronal cell death in the hippocampus (162164)
"Many people interpret thirst as hunger
Another likely mechanism for weight loss is that GLP-1 receptor agonists talk directly to the areas of the brain in charge of feeling full and satisfied, helping you to feel full faster